❄️ WINTER SALEWINTER2020% off
AKT Prep
Official MRCGP Examiner Insights

AKT Feedback Reports

Summaries of official RCGP feedback from the last 4 AKT sittings. Learn where candidates excelled, struggled, and focus your revision on recurring weak areas.

View original reports on RCGP website

Recurring Weak Areas

Topics flagged across multiple sittings — prioritise these in your revision

3 of 4 sittings

Neurology

Recognising classic symptom combinations: MND (mixed UMN/LMN signs), MS (dissemination in time/space), myasthenia (fatiguable weakness), peripheral neuropathy patterns, headache red flags

2 of 4 sittings

Prescribing & Drug Monitoring

Side effects of long-term meds (ACE inhibitors, statins, metformin, SSRIs), monitoring requirements (lithium levels, DMARD bloods, amiodarone TFTs), drug interactions (red flags in BNF)

2 of 4 sittings

Children and Young People

Paediatric cancer recognition (lymphadenopathy, bone pain, pallor), acute illness assessment (NICE traffic light), safeguarding patterns, urological issues (undescended testis, phimosis, UTI investigation)

2 of 4 sittings

Leadership & Administration

GMC confidentiality guidance (when to share without consent), medical records access (GDPR timelines, subject access requests), capacity assessment

2 of 4 sittings

Evidence-based Practice

Data interpretation (forest plots, NNT/NNH, sensitivity/specificity), study design terminology (RCT vs cohort vs case-control), understanding bias types

Master These Weak Areas

Our question bank includes targeted practice on every topic flagged in these reports. Get AI-powered feedback on every wrong answer to build real understanding.

    NeurologyPrescribingPaediatricsData Interpretation

Individual Sitting Reports

AKT 57

28th October 2025

70.63%
Pass Rate
Candidates
1,583
Pass Mark
109
of 160
Mean Score
72.97%
UKG First-Time
88.84%

Performance by Subject Area

Clinical
72.67%
Evidence
69.98%
Organisation
78.8%

Areas of Improvement

  • Urgent and unscheduled careAssessment of acute ill health in adults — recognising red flags and appropriate escalation
  • GastroenterologyGI presentations — e.g. dyspepsia, IBS, inflammatory bowel disease, colorectal symptoms
  • Eyes and visionCommon eye presentations — conjunctivitis, red eye, visual symptoms
  • HaematologyInterpreting FBC abnormalities — anaemia workup, thrombocytopenia, leucocytosis
  • Leadership and administrationChaperone guidance and policies — when required, documentation

Areas Causing Difficulty

  • PrescribingSide-effects of medications for long-term conditions — e.g. ACE inhibitors (cough, hyperkalaemia), metformin (B12 deficiency), statins (myopathy), SSRIs (bleeding risk)
  • ConfidentialityGMC confidentiality guidance — when to share without consent (child protection, DVLA, infectious diseases), capacity issues
  • Paediatric cancerRecognising cancer in children — persistent unexplained symptoms, lymphadenopathy, bone pain, pallor, bruising, abdominal masses
  • Paediatric acute illnessAssessing the acutely unwell child — NICE traffic light, sepsis recognition, dehydration
  • SafeguardingRecognising patterns of abuse — NAI presentations, neglect indicators, fabricated illness
  • NeurologySignificant neurological conditions — combinations of symptoms/signs e.g. motor neurone disease (mixed UMN/LMN), MS (dissemination in time/space), myasthenia (fatiguable weakness)

Key Insight

First sitting with new 160-question format. Neurology remains a persistent challenge — focus on recognising classic symptom combinations that point to specific diagnoses.

AKT 56

9th July 2025

69.12%
Pass Rate
Candidates
1,344
Pass Mark
138
of 200
Mean Score
72.64%
UKG First-Time
85.12%

Performance by Subject Area

Clinical
72.78%
Evidence
69.88%
Organisation
74.33%

Areas of Improvement

  • Children and young peopleCommon childhood conditions — viral exanthems, normal developmental variants, minor illness management
  • Cardiovascular healthLong-term CV management — heart failure (NICE NG106), AF anticoagulation (CHA2DS2-VASc), hypertension targets
  • DermatologyRash recognition — eczema vs psoriasis, drug eruptions, urticaria, acne management

Areas Causing Difficulty

  • Research terminologyStudy design terms — RCT, cohort, case-control, cross-sectional; understanding bias types (selection, recall, attrition); confounding; blinding terminology
  • Infectious disease diagnosticsWhich tests for which infections — e.g. throat swab vs serology, stool PCR, HIV testing window, TB investigations (IGRA vs Mantoux)
  • NeurologyNeurological symptoms and signs — distinguishing upper vs lower motor neurone, cerebellar vs sensory ataxia, peripheral neuropathy patterns

Key Insight

Research methodology questions caught many candidates out. Know your study designs and bias types. For infectious diseases, focus on first-line diagnostic tests in primary care.

AKT 55

30th April 2025

75.92%
Pass Rate
Candidates
1,732
Pass Mark
144
of 200
Mean Score
77.25%
UKG First-Time
91.03%

Performance by Subject Area

Clinical
77.65%
Evidence
77.95%
Organisation
73.34%

Areas of Improvement

  • Duties of a doctorGMC duties — probity, raising concerns, delegation, continuity of care
  • Cancer recognition2-week wait criteria — red flag symptoms for each cancer type, NICE NG12 referral guidance
  • Renal functionAbnormal renal function management — AKI vs CKD, when to refer, medication adjustments
  • Emergency presentationsContinued improvement in acute care — sepsis, anaphylaxis, MI recognition

Areas Causing Difficulty

  • Paediatric urologyCommon urological issues — undescended testis (when to refer), phimosis (normal variants vs pathological), UTI investigation (NICE NG224), bedwetting age thresholds
  • Long-term conditionsKeeping up with guideline changes — recent updates to diabetes (NICE NG28), hypertension (NICE NG136), asthma (NICE NG80), COPD (NICE NG115)
  • NeurologyNeurological symptom recognition — headache red flags, TIA vs stroke, peripheral neuropathy causes, dementia subtypes

Key Insight

Highest pass rate of 2025. Key lesson: sometimes the correct answer is NOT to investigate, prescribe, or refer. Cost-effective, evidence-based watchful waiting is often the right choice.

AKT 54

29th January 2025

71.42%
Pass Rate
Candidates
1,543
Pass Mark
139
of 200
Mean Score
74.23%
UKG First-Time
86.08%

Performance by Subject Area

Clinical
75.25%
Evidence
65.19%
Organisation
75.06%

Areas of Improvement

  • Prescribing knowledgeTherapeutics improvement — appropriate drug choices, dose calculations, common interactions
  • Substance misuseAlcohol and drug management — AUDIT-C scoring, brief interventions, referral thresholds, opioid substitution basics
  • Emergency careEmergency presentations — anaphylaxis management, sepsis 6, acute coronary syndrome

Areas Causing Difficulty

  • Data interpretationCharts and statistics — interpreting forest plots, funnel plots, survival curves, NNT/NNH calculations, sensitivity vs specificity, PPV/NPV
  • Drug monitoringMonitoring requirements — e.g. lithium (levels, renal, thyroid), DMARDs (FBC, LFTs), amiodarone (TFTs, LFTs, CXR), carbimazole (urgent FBC if sore throat)
  • Medical records accessSubject access requests — GDPR timelines, exemptions, third party data, deceased patient records, police requests
  • Early pregnancyPregnancy complications — ectopic symptoms (pain before bleeding), miscarriage types, hyperemesis, early pregnancy unit referral criteria
  • Dermatology treatmentSkin condition management — topical steroid potencies, emollient prescribing, acne ladder, psoriasis treatment pathway
  • Ophthalmology signsEye examination findings — normal vs abnormal fundoscopy (disc pallor, cupping, macular changes), pupil abnormalities (RAPD, Horner), red eye causes
  • Genetic conditionsRecognising genetic syndromes — Down syndrome health surveillance, fragile X features, Williams syndrome, Prader-Willi, neurofibromatosis skin signs

Key Insight

Evidence-based practice score (65.19%) was notably lower than other domains. Watch Professor Michael Harris video tutorials on RCGP website for data interpretation.

Key Advice from Examiners

Exam Strategy

  • The correct answer is sometimes not to investigate, prescribe, or refer
  • "Current national guidance" refers to NICE/SIGN (CKS is broader but NICE takes precedence)
  • For drug calculations, reality-check your answers — dangerous errors are common
  • No negative marking — always answer every question

Revision Focus

  • Learn drug monitoring requirements — use BNF as a revision source
  • Familiarise with common and important drug side effects (especially "red" interactions)
  • Practice data interpretation — RCGP provides video tutorials by Prof Michael Harris
  • Engage regularly with safeguarding learning activities

Practice These Weak Areas Now

Use our AI-powered question bank to focus on the topics candidates struggle with most.